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We present here three expression plasmids for Trypanosoma cruzi adapted to the Gateway® recombination clon-
ing system. Two of these plasmids were designed to express trypanosomal proteins fused to a double tag for tandem 
affinity purification (TAPtag). The TAPtag and Gateway® cassette were introduced into an episomal (pTEX) and 
an integrative (pTREX) plasmid. Both plasmids were assayed by introducing green fluorescent protein (GFP) by 
recombination and the integrity of the double-tagged protein was determined by western blotting and immunofluo-
rescence microscopy. The third Gateway adapted vector assayed was the inducible pTcINDEX. When tested with 
GFP, pTcINDEX-GW showed a good response to tetracycline, being less leaky than its precursor (pTcINDEX).
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Trypanosoma cruzi, Trypanosoma brucei and Leish-
mania major (together named as TriTryp) genome-se-
quencing projects were completed in 2005 (El-Sayed et 
al. 2005). Currently, there are 16 genomes from Leishma-
nia spp: two from T. brucei and nine from T. cruzi strains 
available in the TriTryp database (tritrypdb.org/tritryp-
db). To fully exploit this vast amount of information, it is 
essential to improve and extend the range of genetic tools 
available for analysing the function of genes in vivo.
Among the TriTryp species, T. cruzi is the most tech-
nically limited. Unlike T. brucei for which RNAi-based 
procedures have been widely exploited for exploring gene 
function, in T. cruzi the molecular machinery necessary 
for RNAi has not been detected (da Rocha et al. 2004). 
Additionally, in contrast to T. brucei and Leishmania spp, 
conventional gene knockouts in T. cruzi are notably less 
efficient and hindered by the fact that most genes are en-
coded by multiple-copy gene families, making this tech-
nique laborious and time-consuming (Clayton 1999).
Since the 1980s, several groups have attempted to 
genetically manipulate trypanosomatids. One of the first 
reports of stable transfection in T. cruzi was achieved by 
the electroporation of epimastigotes with the pTEX ex-
pression vector. This episomal plasmid was constructed 
using flanking sequences derived from the glycosomal 
glyceraldehyde-3-phosphate dehydrogenase gene (Kelly 
et al. 1992). The pTEX plasmid was improved a few years 
later by insertion of an 800 bp ribosomal DNA fragment 
upstream of the multiple cloning site. The result, the 
pRIBOTEX integrative plasmid, had a shorter selection 
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time and a mild increase in expression levels (Martínez-
Calvillo et al. 1997). pRIBOTEX was further enhanced 
by the insertion of the upstream region of the TcP2beta 
H1 gene (HX1) next to the putative ribosomal promoter 
element to generate pTREX (Vazquez & Levin 1999). 
All of the vectors described above promote the consti-
tutive expression of cloned genes, which is a limitation 
for studying gene function. To overcome this limitation, 
systems for expressing transgenes in a controlled and re-
pressible manner were developed. One of these vectors 
is pTcINDEX, a stable tetracycline-regulated expres-
sion vector, which integrates into a ribosomal non-tran-
scribed spacer region and has a T7 promoter upstream 
of the polymerase I transcription initiation site. pTcIN-
DEX is used together with the episomal pLew plasmid, 
which constitutively expresses the T7 polymerase and 
tetR genes (Taylor & Kelly 2006).
Other plasmids adapted to T. brucei and Leishmania 
sp. are those used for tandem affinity purification (TAP) 
(Estévez et al. 2001, Panigrahi et al. 2003). The classical 
TAP tag contains two immunoglobulin G (IgG)-binding 
domains for the Staphylococcus aureus protein A (PA) 
and calmodulin-binding peptide (CBP) epitopes sepa-
rated by a spacer region and a cleavage site for Tobacco 
Etch Virus (TEV) protease. In consecutive steps, TAP 
is achieved by the binding of a TAP-tagged protein to 
an IgG column, release of the protein by TEV protease 
cleavage, binding of the CBP-tagged protein to a calmod-
ulin column and final elution of the bound protein by a 
buffer containing ethylene glycol-bis(beta-aminoethyl 
ether)-N,N,N’,N’-tetra acetic acid. One of the require-
ments for successful TAP is the expression of the tagged 
protein at its natural level (Rigaut et al. 1999) because 
over-expression can lead to artificial complex formation.
The Gateway® Technology is a universal cloning 
method that takes advantage of the site-specific recom-
bination properties of bacteriophage lambda (Landy 
1989) to provide a rapid and highly efficient way to 
move a gene of interest into multiple vector systems. 
Such site-specific recombination systems increase clon-
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ing efficiency and decrease time spent at the workbench. 
Gateway® Technology has been recently employed to 
construct a wide variety of vectors for T. cruzi gene ex-
pression. Xu et al. (2009) developed a Multisite Gateway 
strategy to rapidly produce efficient knockout constructs 
that generate specific gene deletions. Batista et al. (2010) 
constructed a flexible platform based on the Gateway® 
cloning system that allows rapid exchange of different 
elements such as promoters, fusion tags, resistant mark-
ers and intergenic regions. Finally, Westergaard et al. 
(2010) constructed the pTREX-A GW plasmid as a tool 
to analyse the nuclear localisation signal of the p14 splic-
ing factor in T. cruzi. Here, we present three new T. cruzi 
vectors adapted to the Gateway® system, two TAPtag 
plasmids (pTEX-TAPtag-GW and pTREX-TAPtag-GW) 
and an inducible pTcINDEX-GW plasmid.
To construct the pTEX-TAPtag-GW and pTREX-
TAPtag-GW vectors, the TAPtag cassette was first 
polymerase chain reaction (PCR)-amplified from the 
pBS1479 TAPtag plasmid (Rigaut et al. 1999) and then 
inserted into the HindIII-XhoI restriction sites. The 
pTEX-TAPtag plasmid has been successfully used in T. 
cruzi to express different fused proteins (Dallagiovanna 
et al. 2008, P Cribb, unpublished observations).
Then, the Gateway® cassette was PCR-amplified 
from the pDEST™17 vector (Invitrogen) and inserted 
into EcoRV-HindIII sites (Fig. 1A, B). To determine the 
functionality of pTEX-TAPtag-GW and pTREX-TAPtag-
GW, the green fluorescent protein (GFP) sequence was 
transferred by recombination (LR) with the LR Clonase® 
II enzyme mix (Invitrogen) into the TAPtag-GW plas-
mids as described by the manufacturer from the previ-
ously constructed pENTR3C-GFP vector. The plasmids 
were maintained in the DB3.1 Escherichia coli strain.
The two obtained GFP expressing plasmids were 
transfected into the T. cruzi Dm28c and CL Brener 
strains. Epimastigotes were grown at 28ºC in liver in-
fusion tryptose (LIT) medium supplemented with 10% 
Fig. 1: restriction maps and genetic elements of the Gateway® plasmids (A) pTEX-TAPtag-GW map. The ampicillin resistance gene (neor), 
Gateway® cassette and TAPtag sequence are flanked by the 5’-upstream and 3-downstream regions of the Trypanosoma cruzi glycosomal gly-
cosomal glyceraldehyde-3-phosphate dehydrogenase gene (gGAPDH) genes. The Gateway® cassette consists of the attR1 and R2 sites (black 
boxes), the chloramphenicol resistance gene (Cmr) and the ccdB gene. The TAPtag cassette consists of the calmodulin-binding peptide (CBP), 
protein A (PA) and a spacer region with a Tobacco Etch Virus (TEV) protease cleavage site; B: pTREX-TAPtag-GW map. This vector has the 
same features as pTEX with the addition of a ribosomal promoter (with a transcription starting point, black arrow head) and the HX1 fragment; 
C: inducible expression vector pTcINDEX-GW. The grey box indicates the HX1 fragment. The T. cruzi actin intergenic region (TcActin IG), the 
T7 transcriptional terminator (T) and the Gateway® cassette are shown. The black flags indicate the T7 promoter and the grey circle denotes 
the location of the tetracycline operator. R-NTS/P is the ribosomal non-transcribed spacer and promoter region used for targeting. The Roman 
numerals I and II indicate the two halves of the targeting sequence cloned in the opposite orientation of that in the genome. The black arrowhead 
indicates the location of the polymerase I transcription start site.
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foetal   bovine   serum   (FBS),   100  μg  mL-1 streptomycin 
and   100   μg  mL-1 penicillin. The parasites were main-
tained by subculture and maintained at cell densities 
ranging between 106-108 cells mL-1. T. cruzi epimastig-
otes were transfected by electroporation. The parasites 
were harvested by centrifugation at 2,000 g for 5 min at 
room temperature, washed once in phosphate-buffered 
saline (PBS) and resuspended in 0.4 mL electroporation 
buffer, pH 7.5 (140 mM NaCl, 25 mM HEPES, 0.74 mM 
Na2HPO4) to a density of 10
8 cells mL-1. Cells were then 
transferred to a 0.2 cm gap cuvette (Bio-Rad, USA) and 
15-­100  μg  of  DNA  was  added.  The  mixture  was  placed  
on ice for 15 min and then subjected to two pulses of 
400  V  and  500  μF  using  GenePulser  II  (Bio-­Rad).  After  
electroporation, cells were maintained on ice until be-
ing transferred into 4-10 mL of LIT medium contain-
ing 10% FBS and then incubated at 28ºC. After 24 h of 
incubation, a selective antibiotic was added to an initial 
concentration  of  125  μg  mL-1. Then, 72-96 h after elec-
troporation, cultures were diluted 1:10 and the antibiotic 
concentration was doubled. Stable resistant cells were 
obtained approximately 30 days after transfection.
Once the lines were selected with G418, we moni-
tored GFP expression by western blotting and fluores-
cence microscopy (Fig. 2). Immunoblot analysis with 
commercial anti-GFP (Santa Cruz Biotechnology) and 
anti-Protein A (Sigma) antibodies showed a single band 
of ~60 kDa, which corresponds to the full fused pro-
tein that is present only in transfected parasites, but not 
in the wild type. No partially synthesised or proteolytic 
products were observed (Fig. 2A). Immunofluorescence 
microscopy of transfected epimastigotes demonstrated 
expression of GFP and the TAP tag, which was detected 
with mouse anti-Protein A antibodies and Alexa Fluor 
555 anti-mouse (Invitrogen) as a secondary antibody. 
We observed a positive signal for PA only in parasites 
that expressed GFP, which have a similar fluorescence 
pattern in the whole cell body, but do not completely co-
localise. This difference is likely because the red signal 
is indirect and comes from the antibodies and the GFP 
signal is more intense (Fig. 2B).
Both pTEX and pTREX-derived plasmids showed 
similar expression rates (data not shown). Finally, it is 
worth mentioning that the expression levels observed for 
the episomal pTEX and integrated pTREX plasmids in 
CL Brener appeared to be less homogeneous than that 
in Dm28c (data not shown). To address the biological 
functions of an unknown or hypothetical protein, it is 
necessary to determine its interacting partners. Co-im-
munoprecipitation using polyclonal antibodies directed 
against the protein of interest depends on the antibody 
specificity and it is a laborious and inefficient method. 
Conversely, TAP is a useful technique for studying pro-
tein-protein interactions at or close to natural expression 
levels with efficient recovery. In principle, the use of a 
generic tag allows for parallel sample preparation with-
out the need for optimising the purification protocol for 
each protein complex, making it suitable for large-scale 
studies. The conversion of pTEX and pTREX-TAPtag to 
the Gateway® System results in an easier and faster ap-
proach. The pTREX-TAPtag plasmid was used by our 
group to identify T. cruzi Bromodomain Factor 2 interac-
tion partners (V Villanova, unpublished observations).
To convert pTcINDEX to the Gateway® system, the 
plasmid  was  digested   (5  μg  of  DNA)  with   the  NruI re-
striction enzyme. The 5’-phosphates were removed with 
calf intestinal alkaline phosphatase and the plasmid was 
ligated with the Gateway® cassette RfA (Gateway® Vector 
Conversion System, Invitrogen) to generate the destina-
tion vector (Fig. 1C), which was maintained in the ccdB 
Survival™ 2 T1R E. coli strain. To determine the func-
tionality of the obtained pTcINDEX-GW vector, the GFP 
open reading frame was transferred by recombination 
(LR) with LR clonase II enzyme (Invitrogen) from the 
entry vector pENTR3C-GFP as previously described.
T. cruzi epimastigotes (CL Brener and Dm28c strains) 
were transfected by electroporation with pTcINDEX-
GW-GFP and pTcINDEX-Red (Taylor & Kelly 2006) as 
Fig. 2: pTEX and pTREX-TAPtag-GW experimental validation (A) 
Coomassie and western blot analysis of total lysates from CL Brener 
wild type cells (Lane 1) and those transfected (2) with pTEX-TAPtag-
GW-GFP or pTREX-TAPtag-GW-GFP. Anti-green fluorescent pro-
tein (GFP) (a-GFP) and anti-protein A (a-protein A) antibodies were 
used. Bound antibodies were detected using peroxidase-labelled anti-
mouse or anti-rabbit immunoglobulin G (IgG) (GE Healthcare) and 
ECL Prime (GE Healthcare) using standard protocols; B: immunoflu-
orescence microscopy of CL Brener transfected with pTEX-TAPtag-
GW-GFP and pTREX-TAPtag-GW-GFP. Parasites were adhered to 
poly-L-lysine coated slides and fixed with 4% paraformaldehyde in 
phosphate-buffered saline (PBS), permeabilised with 0.1% Triton 
X-100 in PBS and then incubated with a-protein A antibodies in 1% bo-
vine serum albumin-PBS for 3 h. Then, the slides were incubated with 
anti-mouse IgG antibody conjugated to Alexa Fluor 555 secondary 
antibodies for 1 h. The slides were mounted with VectaShield (Vector 
Laboratories) in the presence of 2 µg mL-1 4’-6-diamidino-2-phenylin-
dole (DAPI) in PBS. Images were acquired with a Nikon Eclipse TE-
2000-E2 confocal microscope. Adobe Photoshop CS v.8.0.1 (Adobe 
System Incorporated) and Nikon EZ-C1 FreeViewer v.3.70 (Nikon 
Corporation) software were used to analyse the images.
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previously described. Selected CL Brener pTcINDEX-
GW-GFP transformants were cloned by limiting dilu-
tion. One hundred microlitres of diluted culture (with 
the addition of wild type parasites) was transferred to a 
48-well plate and the cells were allowed to grow for 24 h 
prior to addition of the selective antibiotic hygromycin.
Once the lines were selected, we monitored the ex-
pression of the fluorescent proteins in induced and un-
induced cultures by fluorescence microscopy (Fig. 3A). 
GFP was observed in the cultures induced with tetracy-
cline, but not in those under un-induced conditions. In 
Fig. 3: pTcINDEX-GW experimental validation. A: fluorescence mi-
croscopy of Dm28c epimastigotes transfected with pTcINDEX-GW-
green fluorescent protein (GFP) and pTcINDEX-Red before and after 
induction with tetracycline (0.5 µg mL-1 for 96 h). Parasites were fixed 
with 4% paraformaldehyde in phosphate-buffered saline (PBS), per-
meabilised with 0.1% Triton X-100 in PBS and incubated with 2 µg 
mL-1 4’-6-diamidino-2-phenylindole (DAPI) in PBS before mount-
ing the slides with VectaShield (Vector Laboratories). Images were 
acquired with a Nikon Eclipse TE-2000-E2 confocal microscope; B: 
western blot analysis of Dm28c pTcINDEX-GW-GFP total lysates in-
duced with 0.5 µg mL-1 tetracycline for 0, 24, 48 and 72 h. Anti-GFP 
(a-GFP)  and  anti-­α   tubulin  antibodies  were  used.  Bound  antibodies  
were detected with peroxidase-labelled anti-mouse or anti-rabbit im-
munoglobulin G (GE Healthcare) and ECL Prime (GE Healthcare) 
using standard protocols; C: growth curve of Dm28c pTcINDEX-
GW-GFP induced with different concentrations of tetracycline 
(0-5 µg mL-1); D: expression of GFP after induction (0.5 µg mL-1 of 
tetracycline for 96 h) in Dm28c and CL Brener strains transfected 
with pTcINDEX-GW-GFP; E: fluorescence microscopy of Dm28c 
pTcINDEX-GW-GFP at different stages of the life cycle. Parasites 
were fixed with 4% paraformaldehyde in PBS, permeabilised with 
0.1% Triton X-100 in PBS and incubated with 2 µg mL-1 DAPI in PBS 
before mounting the slides with VectaShield (Vector Laboratories). 
Images were acquired with a Nikon Eclipse E300 microscope.
contrast, the pTcINDEX-Red strain (used as a transfec-
tion control) showed leaky expression because we detect-
ed red fluorescence in un-induced parasites. The expres-
sion of GFP was also tested by western blot assays (Fig. 
3B). We observed that between 48-72 h post-induction, 
there were no significant changes in the expression level 
of GFP. Then, we performed growth curves in the pres-
ence of different concentrations of tetracycline (Fig. 3C) 
and observed that the parasites grew normally using up 
to 5 µg mL-1 of the antibiotic. We demonstrated that the 
attB1 and attB2 sequences generated by recombination 
did not affect the expression of exogenous proteins in T. 
cruzi. If anything, these sequences appear to have made 
the vector more efficient because there was no leaky ex-
pression in the Dm28c pTcINDEX-GW-GFP strain.
Again, we observed irregular expression of GFP in 
transfected CL Brener epimastigotes (Fig. 3D). Even af-
ter performing dilution cloning of this cell line, the ex-
pression of GFP was not homogeneous and had a wide 
range of fluorescence intensity among the induced para-
sites, including some cells in which no fluorescence was 
detected. More homogeneous results were observed with 
Dm28c, which is a cloned strain with a smaller genome 
with more homogeneous experimental behaviour. This 
strain also presents good rates of in vitro metacyclogen-
esis and efficiently infects common laboratory mamma-
lian cells. In addition, the genomic sequence of Dm28c 
was recently obtained and incorporated into the TriTryp 
database (Grisard et al. 2014).
We also tested the expression of induced GFP 
throughout the T. cruzi life cycle. Dm28c pTcINDEX-
GW-GFP epimastigotes were washed with PBS and dif-
ferentiated in vitro to trypomastigotes following the pro-
cedure described by Contreras et al. (1988). Briefly, cells 
were washed with PBS and incubated in triatomine arti-
ficial urine (TAU) medium (190 mM NaCl, 17 mM KCl, 
2 mM MgCl2, 2 mM CaCl2, 8 mM phosphate buffer pH 
6.0), reaching a density of 5 x 108 parasites mL-1 at 28ºC 
for 2 h. Then, the cells were diluted 1:100 in TAU3AAG 
Medium (TAU medium supplemented with 10 mM glu-
cose, 2 mM L-aspartic acid, 50 mM L-glutamic acid 
and 10 mM L-proline) and incubated at 28ºC for 72 h. 
Metacyclic trypomastigotes were recovered from the su-
pernatant, whereas non-differentiated epimastigotes re-
mained adhered to the flask surface. Intracellular forms 
(amastigotes) and trypomastigotes were obtained by in-
fecting Vero cells with the metacyclic trypomastigotes 
as previously described (Tonelli et al. 2004). The Vero 
cell line was routinely cultivated in Dulbecco’s Modified 
Eagle’s Medium medium (Gibco) supplemented with 
10% heat-inactivated FBS, 0.15% (w/v) NaHCO3, 100 U 
mL-1 penicillin and 100 mg mL-1 streptomycin at 37ºC in 
a humidified atmosphere containing 5% CO2.
Tetracycline induction was tested in the different life 
cycle stages. First, epimastigotes were induced for 72 h 
and tetracycline was removed during the PBS washing 
step prior to performing the in vitro metacyclogenesis. 
We also assayed the addition of tetracycline in the TAU 
medium of un-induced epimastigotes and Vero cells 
(with intracellular amastigotes) infected by un-induced 
metacyclic trypomastigotes. Finally, we tested the induc-
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tion of trypomastigotes released from infected cells. The 
expression of GFP in the four stages was monitored by 
fluoresce microscopy (Fig. 3D). We observed that each 
developmental stage responded to tetracycline induction. 
Once the expression of GFP was induced, it was main-
tained throughout the cycle. Moreover, the expression 
was maintained for at least one round of infection when 
induced metacyclic trypomastigotes were used. These 
results suggest that induction with tetracycline promotes 
protein expression in all stages (including the non-repli-
cative trypomastigotes) and renders an important amount 
of product that, in the case of a stable protein such as GFP, 
remains in cells during the differentiation processes.
In conclusion, we constructed and tested three new des-
tination vectors for T. cruzi that employ Gateway® Tech-
nology. This recombination cloning system is a rapid and 
highly efficient way to move DNA sequences into multiple 
destination vectors. All plasmids are available for the sci-
entific community and can be requested from the authors.
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